新的抗生素，Clovibactin，杀死细菌而不遇到耐药性

Q4 Biochemistry, Genetics and Molecular Biology

Genetic Engineering & Biotechnology News Pub Date : 2023-10-01 DOI:10.1089/gen.43.10.03

{"title":"新的抗生素，Clovibactin，杀死细菌而不遇到耐药性","authors":"","doi":"10.1089/gen.43.10.03","DOIUrl":null,"url":null,"abstract":"Genetic Engineering & Biotechnology NewsVol. 43, No. 10 News & AnalysisNew Antibiotic, Clovibactin, Kills Bacteria without Encountering ResistancePublished Online:13 Oct 2023https://doi.org/10.1089/gen.43.10.03AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View article\"New Antibiotic, Clovibactin, Kills Bacteria without Encountering Resistance.\" Genetic Engineering & Biotechnology News, 43(10), p. 12FiguresReferencesRelatedDetails Volume 43Issue 10Oct 2023 Information© 2023 by GEN PublishingTo cite this article:New Antibiotic, Clovibactin, Kills Bacteria without Encountering Resistance.Genetic Engineering & Biotechnology News.Oct 2023.12-12.http://doi.org/10.1089/gen.43.10.03Published in Volume: 43 Issue 10: October 13, 2023PDF download","PeriodicalId":50425,"journal":{"name":"Genetic Engineering & Biotechnology News","volume":"1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"New Antibiotic, Clovibactin, Kills Bacteria without Encountering Resistance\",\"authors\":\"\",\"doi\":\"10.1089/gen.43.10.03\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Genetic Engineering & Biotechnology NewsVol. 43, No. 10 News & AnalysisNew Antibiotic, Clovibactin, Kills Bacteria without Encountering ResistancePublished Online:13 Oct 2023https://doi.org/10.1089/gen.43.10.03AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View article\\\"New Antibiotic, Clovibactin, Kills Bacteria without Encountering Resistance.\\\" Genetic Engineering & Biotechnology News, 43(10), p. 12FiguresReferencesRelatedDetails Volume 43Issue 10Oct 2023 Information© 2023 by GEN PublishingTo cite this article:New Antibiotic, Clovibactin, Kills Bacteria without Encountering Resistance.Genetic Engineering & Biotechnology News.Oct 2023.12-12.http://doi.org/10.1089/gen.43.10.03Published in Volume: 43 Issue 10: October 13, 2023PDF download\",\"PeriodicalId\":50425,\"journal\":{\"name\":\"Genetic Engineering & Biotechnology News\",\"volume\":\"1 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Genetic Engineering & Biotechnology News\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1089/gen.43.10.03\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Biochemistry, Genetics and Molecular Biology\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Genetic Engineering & Biotechnology News","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1089/gen.43.10.03","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Biochemistry, Genetics and Molecular Biology","Score":null,"Total":0}

引用次数: 0

摘要

基因工程与生物技术新闻卷。43，第10号新闻与分析新的抗生素，Clovibactin，杀死细菌而不遇到阻力发表在线:2023年10月13日https://doi.org/10.1089/gen.43.10.03AboutSectionsView文章查看全文pdf /EPUB权限和引文spermissionsdownload CitationsTrack引文添加到收藏夹回到出版物分享分享在facebook上推特链接在redditemail查看文章“新的抗生素，Clovibactin，杀死细菌而不遇到阻力。”基因工程与生物技术新闻，43(10)，p. 12 figureresreferencesrelateddetails卷43 issue 10Oct 2023信息©2023 by GEN publishing引用这篇文章:新的抗生素，Clovibactin，杀死细菌而不产生耐药性。基因工程与生物技术新闻。Oct 2023.12-12.http://doi.org/10.1089/gen.43.10.03Published in Volume: 43 Issue 10: October 13, 2023PDF下载

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

New Antibiotic, Clovibactin, Kills Bacteria without Encountering Resistance

Genetic Engineering & Biotechnology NewsVol. 43, No. 10 News & AnalysisNew Antibiotic, Clovibactin, Kills Bacteria without Encountering ResistancePublished Online:13 Oct 2023https://doi.org/10.1089/gen.43.10.03AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View article"New Antibiotic, Clovibactin, Kills Bacteria without Encountering Resistance." Genetic Engineering & Biotechnology News, 43(10), p. 12FiguresReferencesRelatedDetails Volume 43Issue 10Oct 2023 Information© 2023 by GEN PublishingTo cite this article:New Antibiotic, Clovibactin, Kills Bacteria without Encountering Resistance.Genetic Engineering & Biotechnology News.Oct 2023.12-12.http://doi.org/10.1089/gen.43.10.03Published in Volume: 43 Issue 10: October 13, 2023PDF download

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Genetic Engineering & Biotechnology News 工程技术-生物工程与应用微生物

CiteScore

0.20

自引率

0.00%

发文量

210

审稿时长

3-6 weeks

期刊介绍： Genetic Engineering & Biotechnology News (GEN) is the flagship publication of Mary Ann Liebert, Inc. Launched in 1980, GEN was the first publication in this field and remains the key driver in the explosion of the industry, paving the way for the development of new technologies and applications, investment growth, and career opportunities. With nearly 40 years of publishing experience, GEN maintains unrivaled integrity, influence, and expertise that plays a pivotal role in driving the productivity and growth of the industry. Through its cornerstone Magazine, high-frequency newsletters, and dynamic suite of multimedia resources, GEN is the 360-degree resource that researchers and executives depend on for information that is pivotal for their organization’s success. GEN’s breadth of editorial coverage is unrivaled in the industry, providing exclusive coverage of the entire bioproduct lifecycle across five key pillars: Drug Discovery, Bioprocessing, OMICS, Translational Medicine, and Gene Editing.